Alcon at Academy 2026
September 30–October 3, 2026
Anaheim Convention Center
Anaheim, CA
Booth #712
Experience Alcon at Academy 2026
Join us September 30–October 3 in Anaheim to explore innovation across eye care, connect with Alcon experts and discover the science, products and experiences Alcon is bringing to this year’s meeting.
Innovation Spotlight
Stop by Our Booth to See What’s Next for Alcon in Patient Care
The Power of Natural Tears in the Treatment of Dry Eye Disease
Visit the Alcon booth to learn about TRYPTYR® (acoltremon ophthalmic solution) 0.003%, a prescription medication approved by the U.S. FDA for the treatment of the signs and symptoms of Dry Eye Disease. TRYPTYR® is an innovative treatment option that delivers rapid natural tear production as early as day 11.
INDICATIONS AND USAGE
TRYPTYR (acoltremon ophthalmic solution) 0.003% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).
IMPORTANT SAFETY INFORMATION
Warnings and Precautions
Potential for Eye Injury and Contamination: To avoid the potential for eye injury and contamination, advise patients not to touch the vial tip to the eye or other surfaces.
Use with Contact Lenses: TRYPTYR should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted for 15 minutes following administration.
Adverse Reactions
In clinical trials, the most common adverse reaction was instillation site pain (50%).
Please click here for the TRYPTYR Full Prescribing Information.
Innovation You Don’t Want to Miss
Didn't Think Reusable Lenses Could Be Different? Meet PRECISION7® - Redefining the Weekly Contact Lens Experience
When daily disposable lenses are not an option for your patient, recommend a lens that is closest to a daily experience; PRECISION7® - the 1-week replacement lenses with ACTIV-FLO, offering 16 hours of outstanding comfort and precise vision, even on day 7.2-3 Stop by and learn more about why PRECISION7® is the fastest growing reusable contact lens brand in the market*.
*Based on third-party market research; January-February 2026 versus January-February 2025 contact lens prescription volume in the U.S.
NEW WaterInnovations™ Expanded Parameters
Now, you can Say Yes to More4 patients with astigmatism to provide all-day comfort5-7 with our WaterInnovations™ Toric Portfolio - available in more expanded parameters.4 With Alcon as your partner, you can support more of your patients with astigmatism. Start fitting today!
TOTAL30® Multifocal for Astigmatism
TOTAL30® Multifocal for Astigmatism is the World’s FIRST multifocal toric contact lens with Water Gradient Technology, designed to meet the unique needs of astigmatic presbyopes. This innovation delivers exceptional end-of-day comfort, even on day 307**, helping patients stay in contact lenses as their vision evolves with age.
**Rated after at least 12 hours of wear, measured at day 30.
With Dry Eye Science This Advanced, it's a Simple Choice
Systane® PRO Preservative-Free hydrates, restores and protects dry eyes. Stop by the Alcon booth and learn how Systane®’s most comprehensive, longest-lasting formula delivers up to 12 hours of dry eye relief.8-12*
*47% of patients experience meaningful symptom relief at 12 hours (n=153)
Help More Patients Use Their Vision Benefits for Contact Lenses
Many patients may not realize they can use their vision benefits, HSA, or FSA funds toward contact lens purchases. This fall, Alcon will support patient awareness with a national media campaign encouraging patients to use their available benefits for purchase of contact lenses from their local optometrist. Explore Alcon's Vision Benefits Campaign and access ready-to-use patient resources that can help patients understand their savings opportunities and make contact lenses more attainable.
Alcon WaterInnovations™ Immersive Experience Booth #685
Step inside a first-of-its-kind installation on the show floor at this year’s Academy of Optometry.
Alcon is hosting an immersive, interactive experience where water, light, and science converge to showcase the breakthroughs behind Alcon WaterInnovations™ technology. At Alcon, we're driven by a simple belief: when people see brilliantly, they live brilliantly. That's why we aspire to lead the world in life-changing vision innovation.
The Future is Lit, Visit Booth #675
Gain exclusive access to Alcon's Surgical Innovation Suite, a VIP experience showcasing the latest advancements in glaucoma, retina, and refractive care. Explore breakthrough technologies, connect with Alcon experts, and see what's next in ophthalmic innovation.
Beyond the Booth: Scientific Exchange and Live Learning Events
All speakers listed below are Paid Alcon Consultants.
Pharma Lunch Symposium
Wednesday, September 30, 2026
Dry Eye Care: Looking Beyond Today’s Treatment Paradigm
Cory Lappin, OD
Selina McGee, OD
Nate Lighthizer, OD
12:00–1:00PM PT
Anaheim Convention Center, North Level 200
Room: 152
Surgical Dinner Symposia — Two Concurrent Events
Wednesday, September 30, 2026
Transforming In-Clinic Care: Innovations in Glaucoma and Dry AMD Management
Event 1
Nate Lighthizer, OD – Moderator
Mohammad Rafieetary, OD – Valeda PBM
Mitch Ibach, OD – Voyager DSLT
Event 2
April Jasper, OD – Moderator
Mary Beth Yackey, OD – Valeda PBM
Justin Schweitzer, OD – Voyager DSLT
5:30–6:30PM PT
Event 1: Anaheim Convention Center, North Level 200, Room 208
Event 2: Anaheim Marriott, Room Platinum 6
Global Medical Affairs Breakfast Symposium
Thursday, October 1, 2026
TRYPTYR® (acoltremon ophthalmic solution) 0.003% in Dry Eye Disease: Real-World Insights from Clinical Practice and Patient-Reported Outcomes
Marc Bloomenstein, OD, FAAO
Kaleb Abbott, OD, MS, FAAO, FOWNS
Gina Wesley, OD, MS, FAAO
8:00–8:45AM PT
Anaheim Convention Center, North Level 200
Room: 251A
Alcon Science Expert Network Session
Thursday, October 1, 2026
Wavelight® Ray-Tracing-Guided LASIK: Principles and Clinical Outcomes
Arjan Hura, MD and Neda Shamie, MD
6:30PM–8:30PM PST
Morton's the Steakhouse; 1895 South Harbor Boulevard Anaheim, CA 92802
Vision Care Lunch Symposium
Thursday, October 1, 2026
Say Yes to More Possibilities in Astigmatism Correction
Melissa Barnett, OD
Jason Compton, OD
12:00PM–1:00PM PT
Anaheim Convention Center, North Level 200
Room: 253 C
TRYPTYR Dinner Event — Invite Only
Thursday, October 1, 2026
Reframing Dry Eye Management: The role of neuromodulation
Walt Whitley, OD
Jackie Garlich, OD
Jessilin Quint, OD
6:00PM PT
Orchid Ballroom at JW Marriott, Anaheim Resort - 1775 S Clementine St, Anaheim, CA 92802
Invite-only TRYPTYR dinner event.
OWL Signature Event
Thursday, October 1, 2026
OWL Signature Event at AAO
Walt Whitley, OD
Jackie Garlich, OD
Jessilin Quint, OD
5:30–7:00PM PT
Anaheim Marriott, 700 West Convention Way, Anaheim, CA 92802
Invite-only TRYPTYR dinner event.
Surgical Breakfast Symposia — Two Concurrent Events
Friday, October 2, 2026
Transforming In-Clinic Care: Innovations in Glaucoma and Dry AMD Management
Event 1
Nate Lighthizer, OD – Moderator
Jessica Haynes, OD – Valeda PBM
Mitch Ibach, OD – Voyager DSLT
Event 2
April Jasper, OD – Moderator
Mary Beth Yackey, OD – Valeda PBM
Justin Schweitzer, OD – Voyager DSLT
8:00–8:45 a.m. PT
Event 1: Anaheim Convention Center, North Level 200, Room 252 A
Event 2: Anaheim Convention Center; North Level 200, Room 251 C
Vision Care / OTC Lunch Symposium
Friday, October 2, 2026
Future Forward Dry Eye Management
Dr. Jessilin Quint
12:00–1:00 p.m. PT
Anaheim Convention Center, North Level 200, Room 252 A
INDICATIONS AND USAGE
TRYPTYR® (acoltremon ophthalmic solution) 0.003% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).
IMPORTANT SAFETY INFORMATION
Warnings and Precautions
Potential for Eye Injury and Contamination: To avoid the potential for eye injury and contamination, advise patients not to touch the vial tip to the eye or other surfaces.
Use with Contact Lenses: TRYPTYR should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted for 15 minutes following administration.
Adverse Reactions
In clinical trials, the most common adverse reaction was instillation site pain (50%).
Please click here for the TRYPTYR Full Prescribing Information.
The Alcon Booth Experience Booth # 712
Check out our booth in Anaheim. Discover Alcon's latest advancements in Vision Care:
- ✔ Dry Eye
- ✔ Contact Lens
- ✔ Specialty Equipment
- ✔ Digital Health
- ✔ Practice Support
Make sure to explore Alcon’s booth to learn about our products and innovations.
Stay Connected. Discover What’s New with MARLO
Ask for a MARLO demo or learn more about the latest innovation updates and how they’re streamlining patient ordering and practice management. Discover how MARLO keeps you connected to your patients.
Clean. Comfort. Confidence. Alcon’s Trusted Contact Lens Care Solutions
Learn more about how Alcon’s trusted contact lens care portfolio provides a solution for everyone to make life in lenses better. Driven by science, our technology in products like OPTI FREE delivers hydration, all-day comfort,13-16 and CLEAR CARE® PLUS solutions actively cleans and removes debris from your lenses, so your lenses are clean and comfortable17-19 giving wearers the confidence to enjoy every moment in their lenses.
Latest News from Alcon at Academy 2026
See how Alcon is advancing Innovation at Academy 2026 Read the latest announcements highlighting Alcon’s scientific presentations, product innovations and activities at this year’s meeting.
Stay Connected Beyond the Event
Visit AlconScience.com to explore Alcon’s latest scientific resources, data and research, including updates from Academy 2026. Follow MyAlcon on LinkedIn, Facebook and Instagram for product news, customer stories and invitations to special events.
Important information for PRECISION7® (serafilcon A) contact lenses For daily wear or extended wear up to 6 nights for near/far-sightedness. Risk of serious eye problems (i.e., corneal ulcer) is greater for extended wear. In rare cases, loss of vision may result. Side effects like discomfort, mild burning or stinging may occur.
See product instructions for complete wear, care and safety information. 
REFERENCES
TRYPTYR. Prescribing Information. Alcon Inc., 2025.
In a 2-week prospective clinical study in the US; n=181; CLEAR CARE Cleaning & Disinfecting Solution used for cleaning and disinfection; Alcon data on file, 2023.
Zheng Y, Dou J, Wang Y, et al. Sustained release of a polymeric wetting agent from a silicone-hydrogel contact lens material. ACS Omega. 2022;7(33):29223- 29230. doi: 10.1021/acsomega.2c03310.
Alcon data on file, 2026; REF-29086.
Hines B, et. al. Clinical subjective performance of two daily disposable Toric soft contact lenses. Poster presented at: American Optometric Association, Chicago. June 15-18, 2022.
In a 28-day prospective clinical study; n=92; Alcon data on file, 2023; REF-23800. 4. Alcon data on file, 2024; REF-26791.
Based on a clinical performance evaluation of TOTAL30® Multifocal for Astigmatism contact lenses; Alcon, data on file 2025; REF-27092.
Alcon data on file, 2025.
Kesavan S, et al. Macromolecules. 1992;25(7):2026-2032.
Ubels JL, et al. Curr Eye Res. 2004;28(6):437-444.
Moon SW, et al. Cornea. 2010;29(12):1430-1435.
Ng A, et al. Clin Ophthalmol. 2018;12:695-700.
In a 2-week prospective clinical study in the US; n=181; CLEAR CARE Cleaning & Disinfecting Solution used for cleaning and disinfection; Alcon data on file, 2023.
Alcon data on file, 2010. REF-00083
REF-00995- Kern J, Kappell G, Trinh H, et al. Antimicrobial Properties of a Novel Contact Lens Disinfecting Solution. Poster presented at British Contact Lens Association Manchester, UK, May 2011.
REF-00927: Garofalo R, Lemp J. Clinical trial experience with OPTI-FREE PUREMOIST MPDS. Contact Lens Spectrum. 2011;26:Part SPI 44-48
Alcon data on file, 2010.REF-00078
REF-02811- Gabriel MM, McAnally C, Walters R, et al. Biocidal Efficacy of a New Hydrogen Peroxide Disinfecting Solution Against Clinical Bacterial and Yeast Isolates, and Acanthamoeba Species. Investigative Ophthalmology & Visual Science. 2015;56(7):272- 272.
Alcon data on file, 2014. REF-01043.